Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Christine Walsh

Concepts (364)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
50
2024
595
7.720
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
6
2024
133
2.040
 Why?
Neoplasms, Glandular and Epithelial
12
2022
52
1.970
 Why?
Endometrial Neoplasms
11
2022
205
1.920
 Why?
BRCA1 Protein
8
2020
82
1.560
 Why?
BRCA2 Protein
8
2021
68
1.560
 Why?
Genes, BRCA1
10
2023
45
1.300
 Why?
Genes, BRCA2
9
2023
33
1.300
 Why?
Peritoneal Neoplasms
4
2018
104
1.150
 Why?
Adenocarcinoma, Clear Cell
4
2016
14
1.140
 Why?
Cystadenocarcinoma, Serous
9
2019
89
1.010
 Why?
Biomarkers, Tumor
8
2022
1321
0.880
 Why?
Maintenance Chemotherapy
2
2024
42
0.870
 Why?
Germ-Line Mutation
6
2016
176
0.800
 Why?
Neoplasm Recurrence, Local
13
2024
1149
0.790
 Why?
Indazoles
2
2020
85
0.780
 Why?
Bevacizumab
2
2020
168
0.760
 Why?
Neoplasm Staging
14
2021
1471
0.760
 Why?
Piperidines
2
2020
222
0.710
 Why?
Myeloproliferative Disorders
1
2021
21
0.700
 Why?
Sleep, REM
2
2023
44
0.670
 Why?
Polymorphism, Single Nucleotide
15
2018
2158
0.660
 Why?
Gray Matter
1
2021
92
0.630
 Why?
Genetic Predisposition to Disease
15
2023
2378
0.630
 Why?
Phthalazines
1
2020
63
0.620
 Why?
Sleep Apnea Syndromes
1
2021
98
0.620
 Why?
Deoxycytidine
1
2021
220
0.610
 Why?
Female
75
2024
78844
0.600
 Why?
Mutation
14
2023
4075
0.590
 Why?
Cisplatin
1
2021
345
0.580
 Why?
Fallopian Tube Neoplasms
2
2016
19
0.580
 Why?
Aged, 80 and over
23
2021
8333
0.570
 Why?
White Matter
2
2020
153
0.570
 Why?
Genital Neoplasms, Female
3
2018
99
0.570
 Why?
Molecular Targeted Therapy
3
2017
439
0.570
 Why?
Piperazines
2
2020
375
0.560
 Why?
Tumor Suppressor Protein p53
1
2022
534
0.560
 Why?
Genetic Testing
3
2017
480
0.550
 Why?
Sleep Initiation and Maintenance Disorders
1
2021
195
0.550
 Why?
Medical Oncology
2
2020
339
0.550
 Why?
Gynecology
1
2020
181
0.540
 Why?
Breast Neoplasms
11
2023
2382
0.540
 Why?
Thromboplastin
1
2017
67
0.510
 Why?
Antineoplastic Agents
3
2018
2214
0.510
 Why?
Humans
82
2024
145474
0.490
 Why?
Fellowships and Scholarships
1
2020
354
0.480
 Why?
Aged
37
2021
26153
0.480
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2023
41
0.480
 Why?
DNA Repair-Deficiency Disorders
1
2016
5
0.470
 Why?
Digoxin
1
2015
27
0.460
 Why?
Antibodies, Monoclonal, Humanized
1
2021
992
0.430
 Why?
Venous Thrombosis
1
2017
196
0.430
 Why?
Carcinoma, Endometrioid
2
2014
49
0.420
 Why?
DNA-Binding Proteins
3
2012
1480
0.420
 Why?
Hysterectomy
4
2009
138
0.400
 Why?
Prognosis
16
2022
4316
0.400
 Why?
Organoplatinum Compounds
2
2015
65
0.390
 Why?
Survival Rate
9
2021
2090
0.380
 Why?
Middle Aged
39
2021
36215
0.370
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2021
1963
0.370
 Why?
Enzyme Inhibitors
1
2016
820
0.360
 Why?
Loss of Heterozygosity
2
2008
52
0.350
 Why?
Cystadenocarcinoma, Papillary
2
2008
4
0.350
 Why?
Nuclear Proteins
4
2016
740
0.350
 Why?
Cognition
1
2020
1266
0.350
 Why?
Adenocarcinoma, Papillary
1
2011
11
0.340
 Why?
Ovariectomy
4
2023
166
0.320
 Why?
Neoplasms, Multiple Primary
2
2014
58
0.320
 Why?
DNA, Neoplasm
4
2014
158
0.310
 Why?
Alzheimer Disease
3
2023
630
0.300
 Why?
Internship and Residency
1
2020
1267
0.300
 Why?
Venous Thromboembolism
1
2013
328
0.290
 Why?
Platinum
2
2021
48
0.290
 Why?
Uniparental Disomy
1
2008
9
0.290
 Why?
Uterine Neoplasms
4
2014
98
0.290
 Why?
DNA Repair
1
2011
254
0.290
 Why?
Transcription Factors
4
2016
1734
0.280
 Why?
Endonucleases
1
2008
34
0.280
 Why?
Indoles
2
2024
507
0.270
 Why?
Homologous Recombination
2
2020
37
0.270
 Why?
Adult
31
2021
40777
0.260
 Why?
Disease-Free Survival
5
2013
767
0.260
 Why?
CA-125 Antigen
2
2021
13
0.250
 Why?
Risk Factors
14
2023
10885
0.250
 Why?
Drug Resistance, Neoplasm
4
2022
881
0.240
 Why?
Proto-Oncogene Proteins c-mdm2
1
2006
67
0.240
 Why?
Checkpoint Kinase 2
2
2016
27
0.240
 Why?
Neoplasms
1
2021
2906
0.230
 Why?
United States
7
2024
16098
0.230
 Why?
Vaginal Neoplasms
2
2016
19
0.220
 Why?
Surgical Wound Infection
1
2009
329
0.220
 Why?
Survival Analysis
5
2017
1374
0.220
 Why?
Anisotropy
3
2020
73
0.210
 Why?
Obesity, Morbid
1
2009
293
0.210
 Why?
Drug Approval
1
2024
93
0.200
 Why?
United States Food and Drug Administration
1
2024
208
0.200
 Why?
Neoplasms, Unknown Primary
1
2023
20
0.190
 Why?
Medicare
2
2020
903
0.180
 Why?
DNA Methylation
2
2022
674
0.180
 Why?
Neoplasm Grading
7
2019
310
0.180
 Why?
Immunohistochemistry
3
2019
1716
0.180
 Why?
ras Proteins
2
2015
150
0.180
 Why?
Transforming Growth Factor beta
2
2016
474
0.180
 Why?
Lewy Body Disease
1
2022
33
0.180
 Why?
Molecular Diagnostic Techniques
1
2022
103
0.180
 Why?
Case-Control Studies
6
2017
3623
0.170
 Why?
Diffusion Magnetic Resonance Imaging
2
2020
155
0.170
 Why?
Endometriosis
1
2022
58
0.170
 Why?
Poly (ADP-Ribose) Polymerase-1
1
2021
53
0.170
 Why?
Computing Methodologies
1
2020
3
0.170
 Why?
Thrombocytosis
2
2014
6
0.160
 Why?
Leydig Cell Tumor
1
2020
8
0.160
 Why?
Benzamides
1
2021
226
0.160
 Why?
Sleep Wake Disorders
2
2023
314
0.160
 Why?
Population Surveillance
3
2020
484
0.160
 Why?
Hyperandrogenism
1
2020
25
0.160
 Why?
Adaptor Proteins, Signal Transducing
2
2016
425
0.160
 Why?
Diffusion
1
2020
120
0.160
 Why?
Optical Imaging
1
2020
61
0.150
 Why?
Genome-Wide Association Study
6
2022
1407
0.150
 Why?
Proto-Oncogene Proteins
2
2015
624
0.150
 Why?
Retrospective Studies
13
2020
17291
0.150
 Why?
Drug Administration Schedule
1
2021
782
0.150
 Why?
Cell Line, Tumor
4
2016
3542
0.150
 Why?
Fitness Trackers
1
2019
17
0.140
 Why?
Risk Reduction Behavior
2
2018
217
0.140
 Why?
B7-H1 Antigen
1
2021
244
0.140
 Why?
Early Ambulation
1
2019
25
0.140
 Why?
Guidelines as Topic
1
2020
266
0.140
 Why?
Rho Guanine Nucleotide Exchange Factors
1
2018
27
0.140
 Why?
Monomeric GTP-Binding Proteins
1
2018
15
0.140
 Why?
Antineoplastic Agents, Immunological
1
2020
198
0.140
 Why?
Angiogenesis Inhibitors
1
2020
238
0.140
 Why?
Dementia
1
2022
327
0.130
 Why?
Carcinoma in Situ
2
2016
44
0.130
 Why?
Regression Analysis
1
2020
1001
0.130
 Why?
A Kinase Anchor Proteins
1
2018
70
0.130
 Why?
Cost-Benefit Analysis
1
2020
639
0.130
 Why?
Enzyme Multiplied Immunoassay Technique
1
2017
2
0.130
 Why?
Cadherins
1
2019
200
0.130
 Why?
Genetic Counseling
1
2017
80
0.120
 Why?
Postoperative Care
1
2019
286
0.120
 Why?
Salpingectomy
1
2016
15
0.120
 Why?
Remission Induction
1
2017
307
0.120
 Why?
Receptors, Transforming Growth Factor beta
1
2016
55
0.120
 Why?
Randomized Controlled Trials as Topic
2
2020
1747
0.120
 Why?
Oligonucleotide Array Sequence Analysis
2
2008
749
0.120
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
69
0.120
 Why?
Lymphocyte Activation
1
2020
1132
0.120
 Why?
Extracellular Matrix Proteins
2
2015
156
0.120
 Why?
Phosphotransferases (Alcohol Group Acceptor)
1
2016
49
0.120
 Why?
Parkinson Disease
1
2022
599
0.120
 Why?
Los Angeles
2
2018
73
0.120
 Why?
Antigens, CD
1
2019
558
0.110
 Why?
Clinical Trials as Topic
2
2013
1061
0.110
 Why?
Cohort Studies
6
2016
6013
0.110
 Why?
Chemotherapy, Adjuvant
1
2016
423
0.110
 Why?
Genotype
6
2018
1852
0.110
 Why?
Cyclin E
1
2015
23
0.110
 Why?
Proto-Oncogene Proteins c-ets
1
2015
56
0.110
 Why?
SEER Program
1
2015
229
0.110
 Why?
Gonadotropins
1
2014
44
0.110
 Why?
Lymph Node Excision
1
2016
173
0.110
 Why?
Oncogene Proteins
1
2015
62
0.110
 Why?
Enhancer Elements, Genetic
1
2016
191
0.110
 Why?
Myofibroblasts
1
2016
148
0.100
 Why?
Corpus Callosum
1
2014
72
0.100
 Why?
Tumor Suppressor Proteins
1
2016
321
0.100
 Why?
Promoter Regions, Genetic
2
2010
1246
0.100
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2013
54
0.100
 Why?
ATP-Binding Cassette Transporters
1
2014
117
0.100
 Why?
Interleukin-1alpha
1
2013
57
0.100
 Why?
Early Detection of Cancer
3
2021
485
0.100
 Why?
Heterozygote
4
2016
313
0.100
 Why?
Cancer Survivors
1
2018
337
0.100
 Why?
Receptor Protein-Tyrosine Kinases
1
2015
231
0.090
 Why?
Patient Satisfaction
1
2017
709
0.090
 Why?
Lymph Nodes
1
2016
503
0.090
 Why?
Length of Stay
1
2019
1349
0.090
 Why?
Brain Mapping
1
2016
538
0.090
 Why?
Time Factors
3
2021
7123
0.090
 Why?
Prefrontal Cortex
1
2016
334
0.090
 Why?
Cell Adhesion Molecules
1
2013
181
0.090
 Why?
Treatment Outcome
4
2021
11772
0.090
 Why?
Adenocarcinoma
2
2011
925
0.090
 Why?
Cognitive Dysfunction
1
2018
467
0.090
 Why?
Chromosomes, Human, Pair 19
1
2012
27
0.090
 Why?
Health Care Reform
1
2013
109
0.090
 Why?
Gene Expression Regulation, Neoplastic
4
2016
1443
0.090
 Why?
Endometrial Hyperplasia
1
2011
6
0.090
 Why?
T-Lymphocytes
1
2020
1996
0.090
 Why?
Follow-Up Studies
5
2016
5423
0.080
 Why?
Chromosomes, Human
1
2011
44
0.080
 Why?
Progestins
1
2011
66
0.080
 Why?
Terminal Care
1
2015
283
0.080
 Why?
Executive Function
1
2016
470
0.080
 Why?
Prostatic Neoplasms
2
2016
978
0.080
 Why?
Surveys and Questionnaires
2
2021
6066
0.080
 Why?
Magnetic Resonance Imaging
2
2021
3904
0.080
 Why?
Real-Time Polymerase Chain Reaction
3
2016
337
0.080
 Why?
Genetic Association Studies
3
2018
369
0.080
 Why?
Fibroblasts
1
2016
1025
0.080
 Why?
Interleukin-6
1
2014
776
0.080
 Why?
MutL Protein Homolog 1
1
2010
11
0.080
 Why?
Male
9
2021
72842
0.080
 Why?
Mass Screening
2
2010
1360
0.080
 Why?
NF-kappa B
1
2013
666
0.080
 Why?
Mammography
2
2021
166
0.080
 Why?
Microsatellite Instability
1
2010
55
0.080
 Why?
Leiomyomatosis
1
2009
4
0.070
 Why?
Sleep
3
2023
888
0.070
 Why?
Receptors, Estrogen
1
2012
401
0.070
 Why?
Suction
1
2009
32
0.070
 Why?
Incidence
4
2021
2923
0.070
 Why?
Signal Transduction
4
2016
5216
0.070
 Why?
Protein Kinase Inhibitors
1
2015
981
0.070
 Why?
Carcinoma, Papillary
1
2009
77
0.070
 Why?
Polymerase Chain Reaction
1
2011
1041
0.070
 Why?
Artifacts
1
2009
143
0.070
 Why?
Adenocarcinoma, Mucinous
1
2009
76
0.070
 Why?
Alleles
1
2011
894
0.070
 Why?
Ovary
2
2020
233
0.070
 Why?
Cell Differentiation
1
2016
2046
0.070
 Why?
Conization
1
2007
2
0.070
 Why?
Blood Vessels
1
2009
167
0.060
 Why?
Risk
3
2016
919
0.060
 Why?
Gynecologic Surgical Procedures
1
2007
67
0.060
 Why?
Registries
1
2015
2406
0.060
 Why?
Pseudogenes
1
2006
20
0.060
 Why?
Healthcare Disparities
1
2013
735
0.060
 Why?
Fertility
1
2007
173
0.060
 Why?
Genes, Tumor Suppressor
1
2005
85
0.050
 Why?
Pilot Projects
2
2022
1891
0.050
 Why?
Quantitative Trait Loci
2
2018
378
0.050
 Why?
MicroRNAs
1
2011
686
0.050
 Why?
Lymphoma
1
2006
237
0.050
 Why?
Membrane Proteins
1
2011
1164
0.050
 Why?
Kaplan-Meier Estimate
2
2019
969
0.050
 Why?
Tumor Cells, Cultured
2
2016
886
0.050
 Why?
Laparoscopy
1
2009
481
0.050
 Why?
Uterine Cervical Neoplasms
1
2007
268
0.050
 Why?
Phosphatidylinositol 3-Kinases
1
2006
382
0.050
 Why?
Genetic Loci
2
2015
264
0.050
 Why?
Neoplasm Invasiveness
2
2019
506
0.050
 Why?
Leukemia
1
2006
246
0.050
 Why?
Immunoenzyme Techniques
2
2016
200
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
977
0.050
 Why?
Aging
1
2014
1969
0.050
 Why?
Gene Expression
1
2008
1476
0.050
 Why?
RNA, Messenger
3
2016
2803
0.050
 Why?
Age Factors
1
2010
3342
0.050
 Why?
Muscle Hypertonia
1
2022
8
0.050
 Why?
Sensitivity and Specificity
1
2007
1997
0.050
 Why?
Linear Models
2
2015
845
0.050
 Why?
Transcriptome
2
2022
1038
0.040
 Why?
Proto-Oncogene Proteins p21(ras)
2
2015
254
0.040
 Why?
Algorithms
1
2010
1845
0.040
 Why?
Practice Guidelines as Topic
1
2010
1581
0.040
 Why?
Chromatin Immunoprecipitation
2
2016
139
0.040
 Why?
Diagnosis, Differential
2
2016
1508
0.040
 Why?
Virilism
1
2020
6
0.040
 Why?
Sleep Deprivation
1
2023
206
0.040
 Why?
Cell Movement
2
2016
959
0.040
 Why?
Prospective Studies
3
2019
8057
0.040
 Why?
Neuropsychological Tests
2
2016
1134
0.040
 Why?
Young Adult
2
2016
14218
0.040
 Why?
Epigenesis, Genetic
1
2005
679
0.040
 Why?
California
1
2021
471
0.040
 Why?
Ribonucleoproteins, Small Nucleolar
1
2019
5
0.040
 Why?
Mastectomy
1
2020
184
0.040
 Why?
Cell Proliferation
2
2016
2507
0.030
 Why?
Apoptosis
2
2016
2440
0.030
 Why?
Fanconi Anemia Complementation Group N Protein
1
2016
4
0.030
 Why?
Testosterone
1
2020
416
0.030
 Why?
Ultrasonography
1
2020
785
0.030
 Why?
Receptors, Lysosphingolipid
1
2016
13
0.030
 Why?
Electrophoretic Mobility Shift Assay
1
2016
88
0.030
 Why?
Databases, Factual
1
2021
1490
0.030
 Why?
Sphingosine
1
2016
47
0.030
 Why?
Models, Anatomic
1
2016
87
0.030
 Why?
Behavior Therapy
1
2018
296
0.030
 Why?
Gene Frequency
1
2016
487
0.030
 Why?
Lysophospholipids
1
2016
80
0.030
 Why?
Fluorescent Antibody Technique
1
2016
365
0.030
 Why?
Factor Analysis, Statistical
1
2016
291
0.030
 Why?
Apathy
1
2015
8
0.030
 Why?
Aurora Kinase A
1
2015
61
0.030
 Why?
Disease Progression
2
2016
2864
0.030
 Why?
Oxazoles
1
2015
48
0.030
 Why?
E2F Transcription Factors
1
2015
65
0.030
 Why?
Likelihood Functions
1
2015
138
0.030
 Why?
Hyaluronan Receptors
1
2015
104
0.030
 Why?
Mammary Glands, Human
1
2015
68
0.030
 Why?
ATP Binding Cassette Transporter 1
1
2014
13
0.030
 Why?
Lymphatic Metastasis
1
2016
331
0.030
 Why?
Neurologic Examination
1
2015
132
0.030
 Why?
Phenotype
1
2023
3155
0.030
 Why?
Nucleotides
1
2015
129
0.030
 Why?
Thiazoles
1
2015
141
0.030
 Why?
Random Allocation
1
2015
365
0.030
 Why?
Microtubule-Associated Proteins
1
2015
194
0.030
 Why?
Genetic Markers
1
2014
335
0.030
 Why?
Cyclin-Dependent Kinases
1
2015
122
0.030
 Why?
Tubulin
1
2015
146
0.030
 Why?
Microarray Analysis
1
2013
116
0.020
 Why?
Estrogen Receptor alpha
1
2015
151
0.020
 Why?
DNA Mutational Analysis
1
2014
407
0.020
 Why?
Memory, Short-Term
1
2016
268
0.020
 Why?
T-Lymphocytes, Regulatory
1
2016
409
0.020
 Why?
Blotting, Western
1
2016
1179
0.020
 Why?
Electronic Health Records
1
2021
1196
0.020
 Why?
Age of Onset
1
2015
555
0.020
 Why?
Carcinogenesis
1
2015
228
0.020
 Why?
Mice, Nude
1
2015
679
0.020
 Why?
Cells, Cultured
1
2020
4148
0.020
 Why?
Attention
1
2016
461
0.020
 Why?
Hospice Care
1
2015
227
0.020
 Why?
Vagina
1
2014
203
0.020
 Why?
Xenograft Model Antitumor Assays
1
2015
934
0.020
 Why?
Phosphorylation
1
2016
1707
0.020
 Why?
Advance Care Planning
1
2015
244
0.020
 Why?
Chromosomes, Human, Pair 6
1
2011
46
0.020
 Why?
Premenopause
1
2011
125
0.020
 Why?
Evolution, Molecular
1
2015
492
0.020
 Why?
Biomarkers
1
2022
4295
0.020
 Why?
Chromosomes, Human, Pair 1
1
2011
80
0.020
 Why?
Referral and Consultation
1
2017
867
0.020
 Why?
Cell Cycle Proteins
1
2015
630
0.020
 Why?
Health Personnel
1
2017
754
0.020
 Why?
Pyridines
1
2015
609
0.020
 Why?
Predictive Value of Tests
1
2016
2121
0.020
 Why?
3' Untranslated Regions
1
2011
149
0.020
 Why?
Neoplastic Stem Cells
1
2014
409
0.020
 Why?
Precancerous Conditions
1
2011
166
0.020
 Why?
Logistic Models
1
2014
2134
0.020
 Why?
Mice, Knockout
1
2016
3124
0.020
 Why?
Carboplatin
1
2009
162
0.020
 Why?
Transcription, Genetic
1
2015
1454
0.020
 Why?
Multivariate Analysis
1
2011
1547
0.020
 Why?
Mice
2
2016
18329
0.020
 Why?
Brachytherapy
1
2009
132
0.020
 Why?
Paclitaxel
1
2009
257
0.020
 Why?
Parity
1
2007
111
0.020
 Why?
Medical Records
1
2007
192
0.020
 Why?
Chromosomes, Human, Pair 22
1
2006
48
0.010
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2006
108
0.010
 Why?
Combined Modality Therapy
1
2009
1266
0.010
 Why?
Osteosarcoma
1
2006
82
0.010
 Why?
CCAAT-Enhancer-Binding Protein-alpha
1
2005
17
0.010
 Why?
Lymphoma, Non-Hodgkin
1
2006
124
0.010
 Why?
Exons
1
2006
363
0.010
 Why?
CpG Islands
1
2005
163
0.010
 Why?
Reference Values
1
2006
798
0.010
 Why?
Methylation
1
2005
242
0.010
 Why?
Mediator Complex
1
2005
61
0.010
 Why?
Reoperation
1
2007
633
0.010
 Why?
Pregnancy Outcome
1
2007
503
0.010
 Why?
Bone Neoplasms
1
2006
259
0.010
 Why?
Proportional Hazards Models
1
2006
1327
0.010
 Why?
Emergency Service, Hospital
1
2015
2381
0.010
 Why?
Animals
2
2016
38030
0.010
 Why?
Histones
1
2005
666
0.010
 Why?
Leukemia, Myeloid, Acute
1
2006
686
0.010
 Why?
Pregnancy
1
2007
7202
0.010
 Why?
Walsh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (364) concept(s)
_
Co-Authors Expand Description
See all (6) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)